Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reactive chemistry for covalent probe and therapeutic development
R. Justin Grams, Ku‐Lung Hsu
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 3, pp. 249-262
Open Access | Times Cited: 22

Showing 22 citing articles:

A covalent compound selectively inhibits RNA demethylase ALKBH5 rather than FTO
Gan-qiang Lai, Yali Li, Heping Zhu, et al.
RSC Chemical Biology (2024) Vol. 5, Iss. 4, pp. 335-343
Open Access | Times Cited: 14
Highly Specific Miniaturized Fluorescent Monoacylglycerol Lipase Probes Enable Translational Research
Axel Hentsch, Mónica Guberman, Silke Radetzki, et al.
Journal of the American Chemical Society (2025)
Open Access | Times Cited: 1
Molecular Bidents with Two Electrophilic Warheads as a New Pharmacological Modality
Zhengnian Li, Jie Jiang, Scott B. Ficarro, et al.
ACS Central Science (2024) Vol. 10, Iss. 6, pp. 1156-1166
Open Access | Times Cited: 7
An Activity-Based Oxaziridine Platform for Identifying and Developing Covalent Ligands for Functional Allosteric Methionine Sites: Redox-Dependent Inhibition of Cyclin-Dependent Kinase 4
Angel Gonzalez-Valero, Audrey G. Reeves, Annika C. S. Page, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 50, pp. 22890-22901
Open Access | Times Cited: 26
Protein–protein interactions: developing small-molecule inhibitors/stabilizers through covalent strategies
Bobby Lucero, Karol R. Francisco, Lawrence J. Liu, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 7, pp. 474-488
Open Access | Times Cited: 15
A modification-centric assessment tool for the performance of chemoproteomic probes
Ji-Xiang He, Zhengcong Fei, Ling Fu, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 8, pp. 904-912
Open Access | Times Cited: 21
Identification of a Novel Allosteric Binding Site on the Catalytic Domain of NF-κB Inducing Kinase (NIK)
Jared J. Anderson, Daniel A. Harki
RSC Medicinal Chemistry (2025)
Closed Access
Covalent-Allosteric Inhibitors: Do We Get the Best of Both Worlds?
Hui Tao, Bo Yang, Atena Farhangian, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Sulphostin-inspired N-phosphonopiperidones as selective covalent DPP8 and DPP9 inhibitors
Leonard Sewald, Werner W. A. Tabak, Lorenz Fehr, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Global Discovery of Covalent Modulators of Ribonucleoprotein Granules
Anthony M. Ciancone, Kyung Won Seo, Miaomiao Chen, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 20, pp. 11056-11066
Closed Access | Times Cited: 8
Covalent fragment approaches targeting non-cysteine residues
Noémi Csorba, Péter Ábrányi‐Balogh, György M. Keserü
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 11, pp. 802-816
Open Access | Times Cited: 7
Covalent fragment-based ligand screening approaches for identification of novel ubiquitin proteasome system modulators
Elisabeth M. Rothweiler, Paul E. Brennan, K. Huber
Biological Chemistry (2022) Vol. 403, Iss. 4, pp. 391-402
Closed Access | Times Cited: 8
Chemoproteomic capture of RNA binding activity in living cells
Andrew J. Heindel, Jeffrey W. Brulet, Xiantao Wang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Advances in Activity‐Based Protein Profiling of Functional Tyrosines in Proteomes
Jeffrey W. Brulet, Anthony M. Ciancone, Kun Yuan, et al.
Israel Journal of Chemistry (2023) Vol. 63, Iss. 3-4
Open Access | Times Cited: 3
Covalent ligands of nuclear receptors
S. S. Rajan, Ho Sup Yoon
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115869-115869
Closed Access | Times Cited: 3
Emerging Technologies for Epigenetic Drug Discovery

Royal Society of Chemistry eBooks (2024)
Closed Access
Mass Spectrometry and Chemical Biology Approaches for Deconvoluting Epigenetic Targets
Antony J. Burton, Ghaith M. Hamza, Anthony A. Iannetta, et al.
Royal Society of Chemistry eBooks (2024), pp. 50-83
Closed Access
Modulation of Iron Metabolism by New Chemicals Interacting with the Iron Regulatory System
Yoshiaki Tsuji, Jun Ninomiya‐Tsuji, Maurice Y.F. Shen, et al.
(2024)
Closed Access
Modulation of Iron Metabolism by New Chemicals Interacting with the Iron Regulatory System
Yoshiaki Tsuji, Jun Ninomiya‐Tsuji, Maurice Y.F. Shen, et al.
Redox Biology (2024) Vol. 79, pp. 103444-103444
Open Access
Emerging opportunities for intact and native protein analysis using chemical proteomics
Alexis N. Edwards, Ku‐Lung Hsu
Analytica Chimica Acta (2024) Vol. 1338, pp. 343551-343551
Closed Access
An Activity-Based Oxaziridine Platform for Identifying and Developing Covalent Ligands for Functional Allosteric Methionine Sites: Redox-Dependent Inhibition of Cyclin-Dependent Kinase 4
Audrey G. Reeves, Angel Gonzalez-Valero, Patrick J. Moon, et al.
(2022)
Open Access | Times Cited: 2
Exploring the boundaries of ferrocenesulfonyl fluoride chemistry
William Erb, Jean‐Pierre Hurvois, Yury S. Halauko, et al.
Inorganic Chemistry Frontiers (2022) Vol. 9, Iss. 22, pp. 5862-5883
Open Access | Times Cited: 2
Page 1

Scroll to top